Abstract

Background: Aminosalicylates are the most frequently prescribed drugs for patients with Crohn’s disease (CD), yet evidence to support their efficacy as induction or maintenance therapy is controversial.

Tags

Adrenal Cortex Hormones, Adverse Effects, Biological Products, Crohn's Disease, Drug Therapy, Epidemiology, Immunosuppressive Agents, Mesalamine, therapeutic use

Read More